IDH2 and central nervous system cancer: The review “Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas” by Michael Wollring and colleagues discusses PET studies in glioma patients with an isocitrate dehydrogenase (IDH) gene mutation [12].